학술논문

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.
Document Type
Letter
Source
Acta Oncologica. Aug2013, Vol. 52 Issue 6, p1231-1233. 3p. 1 Graph.
Subject
*COMBINED modality therapy
*ADENOCARCINOMA
*COMBINATION drug therapy
*DRUG toxicity
*FLUOROURACIL
*FOLINIC acid
*PANCREATIC tumors
*SURVIVAL analysis (Biometry)
*OXALIPLATIN
*IRINOTECAN
Language
ISSN
0284-186X
Abstract
A letter to the editor is presented which is concerned with research which investigated the safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.